Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 On-Demand Webinar: Microbial In-Use Studies | Contract Pharma
News Releases

On-Demand Webinar: Microbial In-Use Studies

In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.

Released By Alcami Corporation

Microbial in-use (admixture) studies are performed to evaluate the growth of low-level microorganisms inoculated into the diluted drug product and tested at several time points over the prescribed administration time.  These studies are performed to determine if microbial growth will be supported and/or proliferate in the product during the holding period prior to patient administration in the event of inadvertent microbial contamination during product dilution. It is important to understand and comply with the timelines and deadlines surrounding these microbiological procedures. 

 

In this webinar, Alcami’s admixture studies expert, Brent Harlow, will guide you through the necessity of these studies and how to successfully perform them for FDA approval. 

 

Presentation Agenda:

  • Overview and Definitions
  • Time Frames for Performing Admixture Studies
  • FDA Filing and Approval Processes
  • Lessons Learned
  • Q & A Session Following Presentation  

 

Keynote Speaker:

  • Brent Harlow, Scientist

 

Q&A Expert:

  • Angela Harrison, Director of Microbiology
Register Now!

Request more information from Alcami Corporation

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters